In the final part of his Pharma Commerce video interview, Dan Chancellor, Norstella’s vice president of thought leadership, ...

The approaching patent cliff—projected to expose as much as $300 billion in annual drug sales to loss of exclusivity by 2032—is expected to keep pharmaceutical M&A activity active in 2026, but not ...

Delve into the strategic alliance behind TrumpRx. We analyze why Big Pharma is partnering with Trump and what it means for ...

CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategyCompany also discusses its ...

By Michael Erman SAN FRANCISCO, Feb 11 (Reuters) - Some pharmaceutical companies not targeted by President Donald Trump for ...

POTOMAC, MD / ACCESSWIRE / November 6, 2024 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is pleased to announce the publication of a new interview with CEO Ram Mukunda, now ...

IGC Pharma (IGC) announced the publication of a new interview with CEO Ram Mukunda, now available as part of the IMS Spotlight Series.In the interview, Ram Mukunda discusses IGC’s strategic expansion ...

ORLANDO, FLORIDA / ACCESS Newswire / July 25, 2025 / RedChip Companies will air an interview with Lantern Pharma Inc. (Nasdaq:LTRN) on the RedChip Small Stocks, Big Money™ show, a sponsored program on ...

In a recent interview, OptimizeRx Chief Commercial Officer Theresa Greco discussed the company’s evolving strategy in the dynamic digital health space. She highlighted the firm’s focus on expanding ...

GENEVA, Oct 1 (Reuters) - Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer (PFE.N), opens ...